China-based Xiamen ITG Group Co., Ltd. (SHA: 600755) and Shanghai Fosun Health Technology (Group) Co., Ltd have announced a strategic partnership to establish a big health industry fund, collaborate on the commercialization of medical devices, and explore the development and application of health big data. While financial details of the partnership were not disclosed, the collaboration aims to leverage the strengths of both companies to drive innovation in the healthcare sector.
Collaborative Focus on Medical Services and Health Big Data
The two companies pledge to carry out close cooperation in medical services, health big data application and development, medical logistics, and supply chain management. They will focus on technology-driven, science and innovation-led medical and health investment opportunities, tapping into new medical technologies with technical advantages, market potential, and clinical application prospects in various Segmented fields.
Fosun Health’s Extensive Network and Resources
Fosun Health, a subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196, HKG: 2196), has an extensive network that includes 10 Internet hospital licenses and 6,333 beds as of the end of 2022. It also operates 18 general and specialist hospitals and third-party testing institutions across five major economic zones in China, including the Greater Bay Area, Yangtze River Delta, Beijing Tianjin Hebei, Central China, and Sichuan Chongqing. This extensive infrastructure positions Fosun Health as a key player in the Chinese healthcare market, ready to contribute to the partnership’s goals.-Fineline Info & Tech
